Surgical excision of subclinical cortisol secreting incidentalomas: Impact on blood pressure, BMI and glucose metabolism;Bénéfices tensionnels, anthropométriques et métaboliques de l'exérèse chirurgicale des adénomes cortisoliques infracliniques

Annales d'Endocrinologie

Volumn 70, Issue 4, 2009, Pages 211-217

  Mauclere Denost S ^a   Duron Martinaud, S ^a   Nunes, M L ^a   Gatta, B ^a   Fagour, C ^a   Rault, A ^b   Gosse, P ^c   Tabarin, A ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c HÔPITAL SAINT ANDRÉ   (France)

Author keywords

Blood pressure; Subclinical cortisol secreting incidentaloma; Subclinical Cushing's syndrome; Surrenalectomy

Indexed keywords

GLUCOSE; HYDROCORTISONE;

ADRENAL INCIDENTALOMA; ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CUSHINGOID SYNDROME; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE RELEASE; HUMAN; HYPERTENSION; HYPOTENSION; MALE; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; TREATMENT INDICATION; WEIGHT REDUCTION;

ADRENAL GLAND NEOPLASMS; ADRENOCORTICOTROPIC HORMONE; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CUSHING SYNDROME; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED;

EID: 69749104546     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2009.03.005     Document Type: Article

References (35)

1. Terzolo M., Bovio S., Reimondo G., et al. Subclinical Cushing's syndrome in adrenal incidentalomas. Endocrinol Metab Clin North Am 34 (2005) 423-439
2. Erbil Y., Ademoglu E., Ozbey N., Barbaros U., Yanik B.T., Salmaslioglu A., et al. Evaluation of the cardiovascular risk in patients with subclinical Cushing's syndrome before and after surgery. World J Surg 30 (2006) 1665-1671
3. Rossi R., Tauchmanova L., Luciano A., et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85 (2000) 1440-1448
4. Reincke M. Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 29 (2000) 43-56
5. Terzolo M., Pia A., Ali A., Osella G., Reimondo G., Bovio S., et al. Adrenal incidentaloma: a new cause of the metabolic syndrome?. J Clin Endocrinol Metab 87 (2002) 998-1003
6. Terzolo M., Osella G., Alì A., Borretta G., Cesario F., Paccotti P., et al. Subclinical Cushing's syndrome in adrenal incidentaloma. Clin Endocrinol 48 (1998) 89-97
7. Magiakou M.A., Smyrnaki P., and Chrousos G.P. Hypertension in Cushing's syndrome. Best Pract Res Clin Endocrinol Metab 20 (2006) 467-482
8. Zelinka T., Strauch B., Pecen L., and Widimsky J. Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome. J Hum Hypertens 18 (2004) 107-111
9. Imai T., Kilumori T., and Nakao A. Laparoscopic adrenalectomy for incidentalome and bilateral adrenal disease. Asian J Surg 26 (2003) 64-70
10. Tabarin A., Enfer-Vattaut S., and Latrabe V. Incidentalomes surrénaliens. Med Clin Endocrinol Diabète Hors Série (2006) 11-20
11. Tauchmanova L., Pivonello R., De Martino M.C., and Calao A. Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism. Eur J Endocrinol 157 (2007) 359-366
12. Young Jr. W.F. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29 (2000) 159-185
13. Garrapa G.G., Pantanetti P., Arnaldi G., Mantero F., Faloia E., et al. Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. J Clin Endocrinol Metab 86 (2001) 5301-5306
14. Fernandez-Real J.M., Engel W.R., Simo R., Salinas I., Webb S.M., and Study Group of Incidental Adrenal Adenoma. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Clin Endocrinol 49 (1998) 53-61
15. Tauchmanova L., Rossi R., Biondi B., et al. Patient with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 87 (2002) 4872-4878
16. Bernini G., Moretti A., Iacconi P., and Salvetti A. Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur J Endocrinol 148 (2003) 213-219
17. Reincke M., Nieke J., Krestin G.P., and Winkelmann W. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 75 (1992) 826-832
18. Midorikawa S., Sanada H., Hashimoto S., Suzuki T., and Watanabe T. The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol 54 (2001) 797-804
19. Emral R., Uysal A.R., Asik M., et al. Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentalome: clinical, biochemical and surgical outcomes. Endocr J 50 (2003) 399-408
20. Casonato A., Pontara E., Boscaro M., Sonino N., Sartorello F., Ferasin S., et al. Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. Blood Coagul Fibrinolysis 10 (1999) 145-151
21. Pivonello R., Faggiano A., Lombardi G., and Colao A. The metabolic syndrome and cardiovascular risk in Cushing's syndrome. Endocrinol Metab Clin North Am 34 (2005) 327-339
22. Ullian M.E. The role of corticosteroids in the regulation of vascular tone. Cardiovasc Res 41 (1999) 55-64
23. Lindholm J., Juul S., Jorgensen J.O., Astrup J., Bjerre P., Feldt-Rasmussen U., et al. Incidence and late prognosis of Cushing's syndrome: a population-based study. J Clin Endocrinol Metab 86 (2001) 117-123
24. Plouin P.F., Fiquet-Kempf B., Fakhoudi F., Rezolle J.P., and Guéry B. Hypertension and primary hyperaldosteronism. Arch Mal Coeur Vaiss 93 (2000) 1469-1473
25. Andrews R.C., and Walker B.R. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci 96 (1999) 513-523
26. Bjorntorp P. Neuroendocrine perturbations as a cause of insulin resistance. Diabetes Metab Res Rev 15 (1999) 427-441
27. Barry M.K., van Heerden J.A., Farley D.R., Grant C.S., Thompson G.B., and Ilstrup D.M. Can adrenal incidentalomas be safely observed?. World J Surg 22 (1998) 599-603
28. Siren J., Tervahartiala P., Sivula A., and Haapiainen R. Natural course of adrenal incidentalomas: 7-year follow-up study. World J Surg 24 (2000) 579-582
29. Barzon L., Scaroni C., Sonino N., Fallo F., Paoletta A., and Boscaro M. Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 84 (1999) 520-526
30. Catargi B., Rigalleau V., Poussin A., and Tabarin A. Occult Cushing's syndrome in type-2 diabetes. J Clin Endocrinol Metab 88 (2003) 5808-5813
31. Valli N., Catargi B., Ronci N., et al. Biochemical screening for subclinical cortisol secreting adenomas amongst adrenal incidentalomas. Eur J Endocrinol 144 (2001) 401-408
32. Terzolo M., Reimondo G., Bovio S., and Angeli A. Subclinical Cushing's syndrome. Pituitary 7 (2004) 217-223
33. Chervin R.A., Danilowick K., and Pitoia F. A study of 34 cases of adrenal incidentaloma. Medicina 67 (2007) 341-350
34. Mantero F., Terzolo M., Arnaldi G., Osella G., Masini A.M., Ali A., and Study Group on Adrenal Tumors of the Italian Society of Endocrinology. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 85 (2000) 637-644
35. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome a new worldwide definition. Lancet 366 (2005) 1059-1062